Answers are grounded in this paper and cite their sources.
The high rates of pathologic complete response (pCR) after modern systemic therapy observed in patients with HER2-positive and triple-negative breast cancer led to the fact that there was a tendency to reduce surgical activity up to the complete refusal of breast surgery subject to the assessment of complete pathological regression using both radiation diagnostic methods and methods of morphological verification of the tumor bed, such as vacuum-assisted biopsy , and accurate core needle biopsy. This review article summarizes all available data on how to morphologically assess complete pathomorphological response (p CR) after neoadjuvant systemic therapy using core needle biopsies and vacuum-assisted biopsy .
No takes yet. Share an insight, caveat, or question.
Мортада et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: